Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

Extreme Rare Mutations in Lung Cancer (ROS1, TRK, HER2): Treatment opportunities

User Photo
HMP CME

4 years
305 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from the "17th Annual Congress: Perspectives in Lung Cancer", Dr. Lucio Crino? discusses extreme rare mutations in lung cancer (ROS1, TRK, HER2) and the treatment opportunities available for them. A continuing education program is offered as a supplement to this webcast at the following location: http://elc.imedex.com/ELC/Activity-Search.aspx?search=7211 © 2016 Imedex, LLC.
Up Next Autoplay